Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Oyarzabal

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Science (London, England : 1979)|July 31, 2015
Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in miceQingshan Wang, Esteban Oyarzabal, Belinda Wilson, et al.
Glia|July 22, 2014
Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseasesQingshan Wang, Chun-Hsien Chu, Esteban Oyarzabal, et al.
Brain : a Journal of Neurology|February 27, 2015
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease modelsQingshan Wang, Li Qian, Shih-Heng Chen, et al.
Brain, Behavior, and Immunity|June 28, 2019
Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functionsSheng Song, Qingshan Wang, Lulu Jiang, et al.
Glia|March 6, 2015
A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasisLulu Jiang, Shih-Heng Chen, Chun-Hsien Chu, et al.
Chemical Communications (Cambridge, England)|June 13, 2020
Mitochondriotropic lanthanide nanorods: implications for multimodal imagingHarwinder Singh, Sreejesh Sreedharan, Esteban Oyarzabal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2014
Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidaseQingshan Wang, Chun-Hsien Chu, Li Qian, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Science (London, England : 1979)|July 31, 2015
Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in miceQingshan Wang, Esteban Oyarzabal, Belinda Wilson, et al.
Glia|July 22, 2014
Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseasesQingshan Wang, Chun-Hsien Chu, Esteban Oyarzabal, et al.
Brain : a Journal of Neurology|February 27, 2015
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease modelsQingshan Wang, Li Qian, Shih-Heng Chen, et al.
Brain, Behavior, and Immunity|June 28, 2019
Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functionsSheng Song, Qingshan Wang, Lulu Jiang, et al.
Glia|March 6, 2015
A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasisLulu Jiang, Shih-Heng Chen, Chun-Hsien Chu, et al.
Chemical Communications (Cambridge, England)|June 13, 2020
Mitochondriotropic lanthanide nanorods: implications for multimodal imagingHarwinder Singh, Sreejesh Sreedharan, Esteban Oyarzabal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2014
Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidaseQingshan Wang, Chun-Hsien Chu, Li Qian, et al.
Pageof 1